{"name":"Galmed Pharmaceuticals Ltd","slug":"galmed-pharmaceuticals-ltd","ticker":"","exchange":"","domain":"galmed.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"amilo-5MER","genericName":"amilo-5MER","slug":"amilo-5mer","indication":"Other","status":"phase_1"},{"name":"Aramchol","genericName":"Aramchol","slug":"aramchol","indication":"Other","status":"phase_2"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Aramchol free acid","genericName":"Aramchol free acid","slug":"aramchol-free-acid","indication":"Non-alcoholic steatohepatitis (NASH)","status":"phase_3"}]}],"pipeline":[{"name":"amilo-5MER","genericName":"amilo-5MER","slug":"amilo-5mer","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Aramchol","genericName":"Aramchol","slug":"aramchol","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Aramchol free acid","genericName":"Aramchol free acid","slug":"aramchol-free-acid","phase":"phase_3","mechanism":"Aramchol inhibits stearoyl-CoA desaturase 1 (SCD1), an enzyme that converts saturated fatty acids to monounsaturated fatty acids, thereby reducing hepatic lipogenesis and improving liver metabolism.","indications":["Non-alcoholic steatohepatitis (NASH)","Non-alcoholic fatty liver disease (NAFLD)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxNeWdyWDI1WlEzOGlVZEI5WnJiMGVQOHVwVnNkRUtsRDZXOGpjcDdqV09KMHpxa3dwOUhvUEFra3RrVzllQUtRdi03NWNtSWZ3RmR6Z2g3R1VQNTNOMWxQSVUxaGJ0WXR5Nk16OC1jSWRhc3FMSGhIMHd5N1ZjUkZoVE0xdnU2Y2NfeFV0dlRmQ09kZnBKbHlXN3k2a1NJdmI3Qkh6Q3d1eUVtNFhQY05vbkNFaDk4WlNOTzNHR1gzOFg5bThoak1zM0J1WnEyYnJyeVU4ei1xOEpDYTlHMHdyNHJVaHRjY2pEbXpfTWRQbkpnSUU?oc=5","date":"2026-03-31","type":"earnings","source":"prnewswire.com","summary":"Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025 - prnewswire.com","headline":"Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPZl9HYldTd3RsTENHejVyUjFibjVpM3ZxNVhXemx3NEtwT1U3S1lLQk1tT0Z3RldtNGVlMlBfTnFSN3QybGUzenFDVDZBS2xMYXdpSGt6U1FnSkhtUlEtdHhXdTFfaE1QQzRlWHJqdmU1MWNXY2VJUmdoQUtib014TklBcTFuczduNDRQMnRiM3BaS0RLcTJmU3JLU1FMZ0pSRDJ3WFBUeVdIUzk0cjlpZS1XSnY2SThHbEdJcTRGdw?oc=5","date":"2026-03-31","type":"pipeline","source":"Stock Titan","summary":"Galmed posts 2025 annual report online, offers free copies - Stock Titan","headline":"Galmed posts 2025 annual report online, offers free copies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxPQjhjWkRiWThUNG96STFYTkExaEVMWjhQUGlpMzNVZlQ2REd3bFpOdUh1VU5VWFJQemVJX1VfQjVkQkZDazNnSmN5Q2tKWDh5VGN5WGtMSGMxd1JiTWVSVW5EbllJS1VIdVM3dWl2UVhVWlg3TGl0b28xVFNWcEFDX29USHNfaTk4ZWd0YUpxcGkwa043ZjVtUEJKazRteEtSZmdZckJ1RlFHYkJ6NVM4RVp5Y096S2tuVGNFNGduY01aeXYza243XzlWZU1RdFFjckdPN1pXbk5EamIyZVBTeFpIU1ZIcHZxX1kwd2VKV2dlWXFxZFRzQ094TmxTdDh0R0ZTNGozZEs3eXk1Q3liNTFMcTU3LXNhS3NUSG5fUUNGN3c?oc=5","date":"2026-02-13","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: Nuvectis Pharma (NVCT), Tenet Healthcare (THC) and Upstream Bio, Inc. (UPB) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: Nuvectis Pharma (NVCT), Tenet Healthcare (THC) and Upstream Bio, Inc. (","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxOY09GaGZBYmllY0xFWmNGU2VzWkNEVnp6RV9ySTFQSThTaU1PRVFLOWRzdDRCRjNIOXh1UTI0d3V2OE5McHRwN0hzdk1uclNIMjJsWXBWbnpXLXRNVDdNeGoxWEtpUEFwckJVbHdEbGMwWFNad3owbVFXNndEMmRaZVZYSjh6blByN3lJTmF3V2ljZkhERmZ2cC01Tmxtd2IwT1Nlc0NQUzY5RC1JRWZRN1NjQ0JEZ2M2X2JDRFI0am1qUnVfMVRyenBycmp0X0VUbEtoX3VsRFhYTTg?oc=5","date":"2025-11-18","type":"trial","source":"prnewswire.com","summary":"Galmed Announces Meaningful Top Line Results from AM-001 Study of Aramchol Meglumine - prnewswire.com","headline":"Galmed Announces Meaningful Top Line Results from AM-001 Study of Aramchol Meglumine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPQmZULWJtTjlya0d2U2JIc21kYWZtUWMtZWFobDNNN1E0TGVpeWRJRnQ0LTAySFR1UGY5Qk9maXBMSU5SWEFndTd3czE5RUlpMHpGcDRKUU5HMEZ5M3V2QmZhaFluRWpvQ0VlMnJTUHdRS2F0OUNlNGZQalJNRGd5RE1rUVBXSzNSM0VQYjNxT2ZXem9QYzBn0gFWQVVfeXFMTjFHWGtJaGV6ZTl1eXRXVHAtTGlQTWVvNXhEWlkweHQwOWVhcHA3VTJBWWMwanduVjFYQVNIVmlsaFU2cUtNc0xKSDc4QzhQNlNldnBpUHc?oc=5","date":"2025-10-21","type":"deal","source":"Law360","summary":"Strand Hanson Seeks $85M In Pharma Merger Fee Dispute - Law360","headline":"Strand Hanson Seeks $85M In Pharma Merger Fee Dispute - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOd3FIbHZXNkUtZDBfLWlQUXZWVl9PTVVlSFcyUGtPMGU3TW56Wk41U0lTNjkyYTM5WXlFRkduaHFSWjVNUTFTamtwc2ExeEZISFdHX2V5NnExR3VyeW45d1JEeE9WaHpKbVF1Vk12d2ZWTVZWOHpjazQzdDdpRm5YYXkwcWdxSUwwcEE?oc=5","date":"2025-04-28","type":"pipeline","source":"timothysykes.com","summary":"Galmed Pharmaceuticals Stock Surge: What’s Next? - timothysykes.com","headline":"Galmed Pharmaceuticals Stock Surge: What’s Next?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPVTN6OU5sN2tWNWRvbExHQlZQQjZHd19IMXBYZXEycjFGamUtVHJRcGd1ZUlOc0NCQkM3OVpRRDlURm5mSmxGekxGQWUzcWVzemFyYUdwTEhBanpvQUdpSkRGcUphUzlHajRCX3U5SUFqRS1hRXNGMUpreUVxeUEyYktaRzBUWi1jS2x2V2JGcTNoUGs?oc=5","date":"2024-09-17","type":"pipeline","source":"MarketBeat","summary":"Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion? - MarketBeat","headline":"Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOVWJYVC1YMjI2MGtpbEhIamRjdTVwc3FNV1ltUTRqT2NiYlZaUjdUVERBUjdycW9yUXdtcS1zc0w0WEJITkN1aDFXN3lYZ2MwM3hMTG82UTdmaC1adnJQbkx3YWpCZGlZeV9tTi04Z09scXJBSFM5bzc3b2dBMDRlWGQwc3NHQ2FpdGp3VHJlTmFsV3lGVkJFdw?oc=5","date":"2022-08-11","type":"pipeline","source":"BioSpace","summary":"Non-Alcoholic Steatohepatitis Treatment Market Size, Report 2022-2030 - BioSpace","headline":"Non-Alcoholic Steatohepatitis Treatment Market Size, Report 2022-2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1HTE1UWktRalo3QTFoc1BNZkhkMklmeHVIbWxFMnFRY2t2cnRkN3lPY3l5V3NQZVdYWWpPU2N3d01yaFJEbElZb3BCXzJxMm12OFYzQXF5bkQ2RVZ5WVd2ZzA5OEN0ZmNrc2tSMDdUZ0cyUjdhRDh3?oc=5","date":"2021-02-22","type":"trial","source":"calcalistech.com","summary":"Israeli pharmaceutical company Galmed raises $18 million during trial of its main product - calcalistech.com","headline":"Israeli pharmaceutical company Galmed raises $18 million during trial of its main product","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOMThlSG16TDVzU3NVZW9BSEJQclJJYXB6cnpJam1aNU5rYWJJMlBwcmlMNm1ScG9ITkQ2X09RNk5DXzFVME84ZEhOYzJ5aUZFYlBaZkpnbW0wb1E0SXpLcngwbUdCekdTOWs3amc4RlAyNHJwQ01NZXpnNmhUa0UzaHBDaWdsOUlxTEEyLVdaRDEtU1k?oc=5","date":"2020-10-13","type":"deal","source":"BioWorld News","summary":"Galmed partners with Gannex to develop NASH cure - BioWorld News","headline":"Galmed partners with Gannex to develop NASH cure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQV1dsay1nNzROaXZHQ0V6RXlGRlFrU2NUREh1elhESVBDTDNmRVpPYkpoRUlXc2xlazB6M0dZV25VNThKNzVsbkdueGdyUlFrYUFIWjhCajFRaWVIWXNCTDlxXzFtVzZXU2dBRzQ0b2d0eWVsQVpYU3RUSkVfZ014Rmg1Yi1vUlBNdXBiYU1yRVdVYlY5eGxQaW5VZFRoVVF4cWxj?oc=5","date":"2018-06-13","type":"pipeline","source":"BioPharma Dive","summary":"Galmed stock jumps sky-high on mixed results for NASH drug - BioPharma Dive","headline":"Galmed stock jumps sky-high on mixed results for NASH drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE9IdHJxdDE4QVl5MGJqdVJoZXI2ajJLMVd4QVBweXRqWXI4RHJ6R01lVjhpdUNNVEhmUWlnMzUzMF9mNkxPbl94MmZNbWxtblFrTFE?oc=5","date":"2017-05-06","type":"pipeline","source":"Yahoo Finance UK","summary":"Galmed Pharmaceuticals Ltd. (GLMD) stock price, news, quote and history - Yahoo Finance UK","headline":"Galmed Pharmaceuticals Ltd. (GLMD) stock price, news, quote and history","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_1":1,"phase_2":1,"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}